[ORGANIZATION]
Dr. Reddys Farmacêutica do Brasil
Featured in 1 tracked story · first seen
Situations
Anvisa approval of GLP-1 medications in Brazil
2 clusters · 38 sources · last updated
Latest: Anvisa approves five new injectable pens for diabetes and obesity
Brazil’s National Health Surveillance Agency (Anvisa) has approved the registration of five new GLP-1 receptor agonist medication pens for treating diabetes and obesity. These new products include Aribet, Lyrza, and Wylo